Search
Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

Drug-Drug Interactions

Predicting drug interactions through metabolism assays

Syngene offers a complete suite of assays that analyze metabolism-based drug-drug interactions mediated primarily by the cytochrome P450 (CYP) superfamily of enzymes.  These studies help clients analyze their drug candidate’s effect on the CYP450 enzyme and identify potential adverse reactions, thereby enhancing the safety and efficacy of the drug candidate. Our teams measure drug metabolism using both CYP inhibition and induction studies to understand drug exposure and reduce the attrition rate of compounds in later stages.

The CYP inhibition studies include reversible CYP inhibition assays that use discrete and pooled substrate approaches, and time-dependent inhibition assays that involve measuring the values for IC50, Kobs (at low and high concentration), Kinact/ KI, as well as performing studies on liver microsomes.

Our detailed analysis of CYP450 induction includes measuring mRNA levels, enzymatic activity, and cytotoxicity in hepatocytes using a non-destructive methodology. During the incubation process, we measure the levels of concentration in the test compounds and a pre-study helps us assess the solubility of compounds and non-specific binding to test systems.

Our range of assays include:

  • Reversible cytochrome P450 inhibition
  • Time-dependent inhibition
  • Reaction phenotyping (CYP identification)

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements. To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details